Literature DB >> 3114369

Interleukin 1-mediated activation of interleukin 4 (IL 4)-producing T lymphocytes. Proliferation by IL 4-dependent and IL 4-independent mechanisms.

S N Ho, R T Abraham, A Nilson, B S Handwerger, D J McKean.   

Abstract

The role of IL 1 in the activation of IL 4-producing murine T cell clones was investigated by using a calcium ionophore (ionomycin) or a phorbol ester (12-O-tetradecanoylphorbol 13-acetate; TPA) as T cell receptor-independent costimuli. The use of these pharmacologic agents to investigate IL 1-mediated T cell activation revealed two distinct mechanisms of activation. IL 1 in combination with ionomycin (iono/rIL 1) stimulated a proliferative response that was associated with the production of IL 4 as measured by lymphokine bioassay and mRNA studies. Furthermore, inhibition of this proliferative response with an anti-IL 4 monoclonal antibody or cyclosporine indicated that IL 4 functions as an autocrine growth factor. In contrast, IL 1 synergized with TPA (TPA/rIL 1) to induce proliferation in the absence of either IL 4 or IL 2 gene transcription or lymphokine secretion. The IL 4-independence of this activation mechanism was further supported by the failure of both anti-IL 4 antibodies and cyclosporine to inhibit the response. In addition, activation by TPA/rIL 1 caused no detectable alteration in cytoplasmic calcium levels. Both IL 4-dependent and IL 4-independent activation responses were associated with the expression of functional receptors for IL 2 as well as IL 4. Characterization of these activation responses suggests that the synergistic activity of IL 1 during T cell activation is multipotential. The nature of an IL 1-dependent T cell growth response, therefore, may vary depending on the balance of intracellular signals generated concurrently through the T cell receptor complex and other regulatory surface molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114369

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Functional heterogeneity in the process of T lymphocyte activation; barium blocks several modes of T cell activation, but spares a functionally unique subset of PHA-activable T cells.

Authors:  L T Peçanha; G A Dos Reis
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

2.  Lymphoid hyperplasia in transgenic mice over-expressing a secreted form of the human interleukin-1beta gene product.

Authors:  O Björkdahl; P Akerblad; A Gjörloff-Wingren; T Leanderson; M Dohlsten
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

3.  Interleukin-1-induced promotion of T-cell differentiation in mice immunized with killed Listeria monocytogenes.

Authors:  K Igarashi; M Mitsuyama; K Muramori; H Tsukada; K Nomoto
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid.

Authors:  A Belldegrun; A Kasid; M Uppenkamp; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells.

Authors:  R Fernandez-Botran; V M Sanders; T R Mosmann; E S Vitetta
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

6.  In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta.

Authors:  D Boraschi; L Nencioni; L Villa; S Censini; P Bossù; P Ghiara; R Presentini; F Perin; D Frasca; G Doria
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

7.  Interleukin 1 production during accessory cell-dependent mitogenesis of T lymphocytes.

Authors:  N Bhardwaj; L L Lau; S M Friedman; M K Crow; R M Steinman
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.